International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-1
Original Article
A Case of Pickwickian Syndrome presented with CO2 Narcosis with multiple uncontrolled co-morbidities
 ,
 ,
 ,
 ,
Published
Feb. 27, 2024
Abstract

The symptoms of obesity hypoventilation syndrome (OHS), often called "Pickwickian syndrome," include hypercapnia during the day, sleep-disordered breathing, and obesity overall. An exclusionary diagnosis. A worsening of or a persistent condition of increasing dyspnea might be observed in patients. This case study details the symptoms and management of a 61-year-old female patient who arrived with shortness of breath with physical exercise and was diagnosed with severe obesity (BMI: 51.9 kg/m2). Very high levels of carbon monoxide were detected in the arterial blood gas (ABG) study. Hypertension, diabetes, obesity, dyslipidemia, and hypothyroidism were all present in this patient. After the patient was stabilised, they were quickly treated with non-invasive ventilatory (NIV) support and supportive care. The patient was prescribed NIV to use overnight and was discharged.

Recommended Articles
Loading Image...
Volume-5, Issue-1
Citations
1122 Views
79 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved